ArticleFrontiers in endocrinology2022
Favorable Genotypes of Type III Interferon Confer Risk of Dyslipidemia in the Population With Obesity.
Tiantian Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it